Entities / Company
Insulet (United States).
insulin delivery device company
- Reports this week
- 0
- Active events
- 0
- Connections
- 53
What's happening
One to three months ago
Gone quiet
No new reports in 90+ days-
Insulet (United States) was trading at a more expensive price relative to its industry peers on June 28, 2025.Speculative1 report
-
Medicare spending cuts are affecting diabetes device companies like Insulet and Dexcom.Speculative2 reports1 development inside
-
Insulet (a U.S. company) was involved in a development concerning Quantum Computing on July 17, 2025.Some support1 report
-
Insulet Corporation, headquartered in Acton, Massachusetts, outperformed both the S&P 500 Index and the Health Care Select Sector SPDR Fund on July 24, 2025.Some support2 reports
-
Insulet stock underperformed the broader market on August 7, 2025.Some support1 report
-
Insulet developed and marketed the Omnipod system and integrated it with the Personal Diabetes Manager on August 11, 2025.Some support1 report
-
Insulet management is scheduled to present at conferences in Boston and New York City on August 19, 2025.Some support1 report
-
Insulet introduced Omnipod 5 in Italy, Denmark, Finland, Norway, and Sweden, alongside receiving FDA clearance for type 2 label expansion.Some support2 reports
-
Insulet stock significantly outperformed the broader market index on August 26, 2025.Some support1 report
-
Eric Benjamin was appointed Chief Operating Officer and Manoj Raghunandanan was appointed Chief Growth Officer at Insulet on August 26, 2025.Some support2 reports
-
Zacks Investment Research provided stock analysis and ratings for Insulet (Q104480795), which is part of the Omnipod Insulin Management System (PDM), on August 27, 2025.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Insulet (United States) this week
News at the entities that move Insulet (United States) most-
Bank of America OperationalThe Office of the Comptroller of the Currency and U.S. Treasury fined Bank of America for reporting and compliance failures.Moves Insulet (United States)
-
Eric StructuralJared Kushner founded the investment fund Affinity Partners, which is now facing scrutiny from James Comer and other sources regarding its ethics and its ties to Donald Trump's influence.Moves Insulet (United States)
-
Wells Fargo Mentioned togetherGovernor Kim Reynolds relies on taxpayer relief funds while a major company, Wells Fargo, receives corporate tax cuts in Iowa.Moves Insulet (United States)
-
Denmark Shared contextTrump made statements on immigration, preferring Denmark, targeting Ossoff over Haiti legislation, and citing Libya as undesirable.Moves Insulet (United States)
-
Finland Shared contextGoogle's data center projects in Finland are being halted pending environmental assessments.Moves Insulet (United States)
Connections
The 6 strongest of 53, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Dexcom Operational
The companies actively compete in the patient monitoring sector while also achieving functional integration between their respective products.
-
Eric Structural
Eric serves as the Chief Operating Officer of Insulet and was involved in launching key Omnipod products.
-
Bank of America Operational
Bank of America analysts have inquired about Insulet's growth strategy and acceleration in type 2 diabetes treatment.
-
Denmark Shared context
Insulet operates and introduces its products within the market of Denmark.
-
Wells Fargo Mentioned together
Wells Fargo analysts have shown interest in Insulet's customer starts and general U.S. growth trends.
-
Finland Shared context
Insulet operates and launched its Omnipod 5 product within the market of Finland.
History
Events by the month they beganJune 2026
12 events- On August 14, 2025, financial institutions inquired about market trends, including type 2 diabetes acceleration, U.S. growth variability, and international growth drivers.
- Insulet (United States) was trading at a more expensive price relative to its industry peers on June 28, 2025.
- Medicare spending cuts are affecting diabetes device companies like Insulet and Dexcom.
- Insulet (a U.S. company) was involved in a development concerning Quantum Computing on July 17, 2025.
- Insulet Corporation, headquartered in Acton, Massachusetts, outperformed both the S&P 500 Index and the Health Care Select Sector SPDR Fund on July 24, 2025.
- Insulet stock underperformed the broader market on August 7, 2025.
- Insulet developed and marketed the Omnipod system and integrated it with the Personal Diabetes Manager on August 11, 2025.
- Insulet management is scheduled to present at conferences in Boston and New York City on August 19, 2025.
- Insulet introduced Omnipod 5 in Italy, Denmark, Finland, Norway, and Sweden, alongside receiving FDA clearance for type 2 label expansion.
- Insulet stock significantly outperformed the broader market index on August 26, 2025.
- Eric Benjamin was appointed Chief Operating Officer and Manoj Raghunandanan was appointed Chief Growth Officer at Insulet on August 26, 2025.
- Zacks Investment Research provided stock analysis and ratings for Insulet (Q104480795), which is part of the Omnipod Insulin Management System (PDM), on August 27, 2025.